All Eli Lilly articles
-
NewsLilly and UnitedHealth launch trial of COVID-19 antibody
Drugmaker Eli Lilly and Co and insurer UnitedHealth Group on Friday said they have partnered to conduct a study of Lilly’s COVID-19 antibody treatment bamlanivimab in high-risk Medicare patients.
